• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The International journal of drug policy >Barriers to access for Canadians who use cannabis for therapeutic purposes
【24h】

Barriers to access for Canadians who use cannabis for therapeutic purposes

机译：使用大麻进行治疗的加拿大人的进入障碍

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background: There is increased interest in the therapeutic potential of cannabis in recent decades. Canada, the Netherlands, Israel and some states in the United States have developed programs to allow access to cannabis for therapeutic purposes (CTP). In Canada, enrollment in the federal CTP program represents fewer than 5% of the estimated users of CTP. The discrepancy between the number of Canadians who report using CTP and the rate of utilization of the federal CTP program suggests the existence of barriers to access to this program. Methods: In the present study we employ a health services analytical framework to examine barriers to access to CTP among 628 current CTP users. We define barriers to access as areas of poor fit between clients and services. We use five dimensions of accommodation, accessibility, availability, affordability, and acceptability to examine access to CTP. Results: Our findings reveal that it is difficult for Canadians to find a physician to support their application to access CTP. Accessing CTP from unauthorized sources was common; only 7% of respondents accessed CTP exclusively from authorized sources. Access to CTP was positively associated with the presence of medical cannabis dispensaries, which were not included in the regulatory regime. Access to CTP varied by medical condition and general quality of health. Affordability of CTP was a substantial barrier to access. Conclusions: Strategies need to be developed to encourage scientific inquiry into CTP and address the barriers to access to CTP and the stigma and controversy that surround CTP and strain patient-physician relationships.
机译：背景：近几十年来，人们对大麻的治疗潜力越来越感兴趣。加拿大，荷兰，以色列和美国的某些州制定了计划，以允许出于治疗目的使用大麻（CTP）。在加拿大，联邦CTP计划的注册人数不到CTP估计用户的5％。报告使用CTP的加拿大人数量与联邦CTP计划的使用率之间的差异表明，存在使用该计划的障碍。方法：在本研究中，我们采用健康服务分析框架来检查628名当前CTP用户中获得CTP的障碍。我们将访问障碍定义为客户和服务之间不适合的区域。我们使用容纳，可访问性，可用性，可负担性和可接受性五个维度来检查对CTP的访问。结果：我们的发现表明，加拿大人很难找到医师来支持其访问CTP的申请。从未经授权的来源访问CTP很常见;仅7％的受访者专门从授权来源访问了CTP。获得CTP与医疗大麻药房的存在有正相关关系，而医疗大麻药房并未纳入监管制度。获得CTP的条件因医疗条件和总体健康水平而异。 CTP的可负担性是获取信息的主要障碍。结论：需要制定策略以鼓励科学地对CTP进行研究，并解决获得CTP的障碍以及围绕CTP的污名化和争议以及使患者与医师之间的关系紧张的问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号